1,3,4-Oxadiazole-naphthalene hybrids as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative activity, apoptotic effect, and in silico studies M Hagras, MA Saleh, RR Ezz Eldin, AA Abuelkhir, EG Khidr, ... Journal of enzyme inhibition and medicinal chemistry 37 (1), 386-402, 2022 | 36 | 2022 |
Exploring the structure-activity relationships of diphenylurea as an antibacterial scaffold active against methicillin-and vancomycin-resistant Staphylococcus aureus MM Elsebaie, HTN El-Din, NS Abutaleb, AA Abuelkhir, HW Liang, AS Attia, ... European Journal of Medicinal Chemistry 234, 114204, 2022 | 14 | 2022 |
New thiazolidine-2, 4-diones as effective anti-proliferative and anti-VEGFR-2 agents: Design, synthesis, in vitro, docking, MD simulations, DFT, ADMET, and toxicity studies H Elkady, AA Abuelkhir, M Rashed, MS Taghour, MA Dahab, HA Mahdy, ... Computational Biology and Chemistry 107, 107958, 2023 | 10 | 2023 |
In vitro and in silico evaluation of new thieno [2, 3-d] pyrimidines as anti-cancer agents and apoptosis inducers targeting VEGFR-2 SA El-Metwally, AA Abuelkhir, H Elkady, MS Taghour, IM Ibrahim, ... Computational Biology and Chemistry 106, 107928, 2023 | 9 | 2023 |
Novel phenylthiazoles with a tert-butyl moiety: promising antimicrobial activity against multidrug-resistant pathogens with enhanced ADME properties M Hagras, AA Abuelkhir, NS Abutaleb, AM Helal, IM Fawzy, M Hegazy, ... RSC advances 14 (2), 1513-1526, 2024 | 2 | 2024 |
Position switch of phenylthiazoles: novel compounds with promising anti-MRSA USA300 AA Abuelkhir, M Omara, YI Nagy, AE Gouda, AS Attia, AS Mayhoub, ... Medicinal Chemistry Research, 1-17, 2024 | | 2024 |